Efficacy and Safety of a New Dilution and Injection Volume of AbobotulinumtoxinA for the Treatment of Glabellar Lines
Clinical trial NCT03960957 · COMPLETED
Trial details
- NCT number
- NCT03960957
- Sponsor
- Galderma R&D
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-17
- Primary completion
- 2019-09-27
- Enrollment
- 301
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.